These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18765684)

  • 1. Nonenzymatic formation of a novel hydroxylated sulfamethoxazole derivative in human liver microsomes: implications for bioanalysis of sulfamethoxazole metabolites.
    Sanderson JP; Hollis FJ; Maggs JL; Clarke SE; Naisbitt DJ; Park BK
    Drug Metab Dispos; 2008 Dec; 36(12):2424-8. PubMed ID: 18765684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes.
    Cribb AE; Spielberg SP; Griffin GP
    Drug Metab Dispos; 1995 Mar; 23(3):406-14. PubMed ID: 7628308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers.
    Mitra AK; Thummel KE; Kalhorn TF; Kharasch ED; Unadkat JD; Slattery JT
    Clin Pharmacol Ther; 1996 Mar; 59(3):332-40. PubMed ID: 8653996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine.
    Cribb AE; Spielberg SP
    Drug Metab Dispos; 1990; 18(5):784-7. PubMed ID: 1981737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by atovaquone of CYP2C9-mediated sulphamethoxazole hydroxylamine formation.
    Miller JL; Trepanier LA
    Eur J Clin Pharmacol; 2002 Apr; 58(1):69-72. PubMed ID: 11956677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
    Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A
    Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfamethoxazole is metabolized to the hydroxylamine in humans.
    Cribb AE; Spielberg SP
    Clin Pharmacol Ther; 1992 May; 51(5):522-6. PubMed ID: 1587066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of a new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients.
    Goda R; Nagai D; Akiyama Y; Nishikawa K; Ikemoto I; Aizawa Y; Nagata K; Yamazoe Y
    Drug Metab Dispos; 2006 May; 34(5):828-35. PubMed ID: 16507648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection.
    Cribb AE; Nuss CE; Alberts DW; Lamphere DB; Grant DM; Grossman SJ; Spielberg SP
    Chem Res Toxicol; 1996 Mar; 9(2):500-7. PubMed ID: 8839055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural elucidation of hydroxylated metabolites of the isoflavan equol by gas chromatography-mass spectrometry and high-performance liquid chromatography-mass spectrometry.
    Rüfer CE; Glatt H; Kulling SE
    Drug Metab Dispos; 2006 Jan; 34(1):51-60. PubMed ID: 16199471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.
    Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA
    Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing and minimizing time-dependent inhibition of cytochrome P450 3A in drug discovery: a case study with melanocortin-4 receptor agonists.
    Tang W; Stearns RA; Wang RW; Miller RR; Chen Q; Ngui J; Bakshi RK; Nargund RP; Dean DC; Baillie TA
    Xenobiotica; 2008 Nov; 38(11):1437-51. PubMed ID: 18841517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-ketocholanoic acid is the major in vitro human hepatic microsomal metabolite of lithocholic acid.
    Deo AK; Bandiera SM
    Drug Metab Dispos; 2009 Sep; 37(9):1938-47. PubMed ID: 19487251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes.
    Li W; Liu Y; He YQ; Zhang JW; Gao Y; Ge GB; Liu HX; Huo H; Liu HT; Wang LM; Sun J; Wang Q; Yang L
    Xenobiotica; 2008 Dec; 38(12):1551-65. PubMed ID: 18982531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF525A) revisited: comparative cytochrome P450 inhibition in human liver microsomes by SKF525A, its metabolites, and SKF-acid and SKF-alcohol.
    Franklin MR; Hathaway LB
    Drug Metab Dispos; 2008 Dec; 36(12):2539-46. PubMed ID: 18799803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of new flavone-8-acetic acid metabolites using mouse microsomes and comparison with human microsomes.
    Pham MH; Auzeil N; Regazzetti A; Dauzonne D; Dugay A; Menet MC; Scherman D; Chabot GG
    Drug Metab Dispos; 2007 Nov; 35(11):2023-34. PubMed ID: 17664249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sub one minute inhibition assays for the major cytochrome P450 enzymes utilizing ultra-performance liquid chromatography/tandem mass spectrometry.
    Rainville PD; Wheaton JP; Alden PG; Plumb RS
    Rapid Commun Mass Spectrom; 2008 May; 22(9):1345-50. PubMed ID: 18381621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878), a novel 5-hydroxytryptamine (5-HT)1A agonist/5-HT3 antagonist, in human hepatic cytochrome P450 enzymes.
    Minato K; Suzuki R; Asagarasu A; Matsui T; Sato M
    Drug Metab Dispos; 2008 May; 36(5):831-40. PubMed ID: 18238859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of novel adenine dinucleotide phosphate conjugates of imatinib in incubations with rat and human liver microsomes.
    Ma S; Subramanian R; Xu Y; Schrag M; Shou M
    Drug Metab Dispos; 2008 Dec; 36(12):2414-8. PubMed ID: 18799804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.